Skip to main content
. 2009 Nov 20;35:37. doi: 10.1186/1824-7288-35-37

Figure 7.

Figure 7

Potential therapeutic use of B1 and B2 kinin receptors (B1R, B2R) modulators to prevent anthracycline-induced myocardial damage.